Integrase inhibitors

AIDS 2008: Is the HIV drug pipeline drying up?

The International AIDS Conference heard promising reports about the newer HIV treatments designed to help treat people with advanced and drug-resistant HIV, all of which are now available in Australia.

IAS 2007: Promising signs

A major HIV/AIDS medical conference in Sydney has generated lots of news on the treatments front, reports Paul Kidd.

CROI 2007: A great leap forward

A major scientific conference on HIV has wound up with promising news on treatments which could signal a significant improvement in HIV treatment for the first time in some years.

New tricks

Two new drugs have recently become available through the Special Access Scheme, providing people with limited treatment options two important new possibilities. KIRSTY MACHON reports.

SAS programs open for TMC-125, MK-0518

Special Access Scheme (SAS) programs are now open to allow early access to two new antiretroviral drugs. This scheme allows for access to these medications while they are still in the final stages of clinical research.

Time to deliver

The 16th International AIDS Conference highlighted numerous important and promising developments in HIV treatments. JOHN DAYE reports.

Looking forward, looking back

In September 2006, the International Association of Physicians in AIDS Care will mark a decade of highly active antiretroviral therapy. Has it really been 10 years since the so-called Protease Moment? KIRSTY MACHON reports on where we have come from – and where to from here.

Rocky Mountain CROI

 The 13th annual Conference on Retroviruses and Opportunistic Infections (CROI) took place in Denver, Colorado, from February 5 to 8. The major breaking news from this conference was the premature cancellation of the SMART study, but as usual, this important conference produced a great deal more than a single story.